期刊文献+

重症监护病房的细菌分布及鲍曼不动杆菌的耐药性分析 被引量:3

Analysis of bacteria distribution resistance of Acinetobacter baumannii in Intensive Care Unit
下载PDF
导出
摘要 目的 分析重症监护病房(ICU)的细菌分布及鲍曼不动杆菌的耐药性.方法 回顾性分析2009年1月至2013年9月内蒙古自治区人民医院ICU感染患者中分离出的1 079株菌株的病原菌分布和耐药性;细菌鉴定和药物敏感试验采用VITEK 2 Compact全自动细菌培养鉴定仪.结果 ICU患者中革兰阴性杆菌分离率为76.3% (823/1 079),其中鲍曼不动杆菌为29.2% (315/1 079),标本以痰液最多,为64.0%(691/1 079);耐亚胺培南鲍曼不动杆菌(IRAB)的检出率为91.7%(289/315).IRAB呈多重耐药,对复方磺胺甲u恶唑、妥布霉素、庆大霉素、左氧氟沙星、环丙沙星、氨苄西林舒巴坦、哌拉西林他唑巴坦、头孢他啶、头孢曲松、头孢吡肟和哌拉西林的耐药率分别为68.9%(199/289)、89.2%(257/289)、93.1% (269/289)、94.1%(272/289)、99.7%(288/289)、98.6%(285/289)、98.6% (285/289)、99.3%(287/289)、99.3%(287/289)、99.7%(288/289)和100.0%(289/289),对阿米卡星耐药率较低,为22.9%(62/271).IRAB对上述12种抗菌药物的耐药率,除复方磺胺甲(噁)唑外,均明显高于非IRAB,差异均有统计学意义(均P<0.05).结论 鲍曼不动杆菌在ICU的检出率较高,IRAB的分离率和耐药性较高,应加强耐药性监测,合理选用抗菌药物,有效控制IRAB的感染及流行. Objective To analyze the bacteria distribution and resistance of Acinetobacter baumannii in Intensive Care Unit(ICU).Methods Infection distribution and drug resistance of l 079 strains of pathogenic bacteria of the patients in ICU were retrospectively analyzed from January 2009 to September 2013 ; the bacteria identification and drug sensitivity were tested by VITEK 2 Compact automatic bacteria identification instrument.Results Pathogenic bacteria isolated from ICU patients with Gram negative bacilli was 76.3%,(823/1 079),in which Acinetobacter baumannii was 29.2% (315/1 079).Most specimens was from sputum (64%,691/1 079) ; imipenem resistant Acinetobacter (Bauman IRAB) detection rate was 91.7% (289/315).IRAB shows multiple drug resistance; the resistant rates of the compound sulfamethoxazole,tobramycin and gentamicin,ofloxacin,ciprofloxacin,ampicillin/ sulbactam,and piperacillin/ Tazobactam,cephalosporin,ceftriaxone,cefepime and piperacillin were 68.9% (199/289),89.2% (257/289),93.1% (269/289)and 94.1% (272/289),99.7% (288/289) and 98.6% (285/289),98.6% (285/289) and 99.3% (287/289),99.3% (287/289) and 99.7% (288/289) and 100.0% (289/289) respectively.The resistant rate for amikacin was 22.9% (62/271).Except compound sulfamethoxazole,resistance to other 11 kinds of antimicrobial agents was evidently higher in IRAB than that to non-IRAB (P 〈 0.05).Conclusion The detection rate of Bauman Acinetobacter in ICU is high; the isolation rate and drug resistance of IRAB is high.
出处 《中国医药》 2014年第12期1816-1818,共3页 China Medicine
基金 内蒙古自治区自然科学基金(2013MS11113)
关键词 亚胺培南 鲍曼不动杆菌 重症监护室 多重耐药 Imipenem Acinetobacter baumannii Intensive Care Unit Multi drug resistance
  • 相关文献

参考文献19

二级参考文献214

共引文献850

同被引文献51

  • 1中华人民共和国卫生部.多重耐药菌医院感染预防与控制技术指南(试行)[S].2011.
  • 2中华人民共和国卫生部,第84号令.抗菌药物临床应用管理办法[s].2012.
  • 3Gordon NC,Wareham DW.Multidrug-resistant Acinetobacter baumannii:mechanisms of virulence and resistance[J].Int J Antimicrob Agents,2010,35(3):219-226.
  • 4Tasbakan MS,Pullukcu H,S ipahi OR,et al.Is tigecycline a good choice in the treatment of multidrug-resistant Acinetobacter baumannii pneumonia[J].J Chemother,2011,23(6):345-349.
  • 5Taherikalani M,Maleki A,Sadeghifard N,et al.Dissemination of class 1,2and 3 integrons among different multidrug-resistant isolates of Acinetobacter banmannii in Tehran hospitals,Iran[J].Pol J Microbiol,2011,60(2):169-174.
  • 6Gurung J,Khyriem AB,Banik A,et al.Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit[J].Indian J Crit Care Med,2013,17(4):214-218.
  • 7邓欣,温伟洪,常惠礼.综合重症监护病房细菌分布及耐药性分析[J].医药前沿,2014(16):81-82.
  • 8陈佰义,何礼贤,胡必杰,倪语星,邱海波,石岩,施毅,王辉,王明贵,杨毅,张菁,俞云松.中国鲍曼不动杆菌感染诊治与防控专家共识[J].中华医学杂志,2012,92(2):76-85. 被引量:843
  • 9王炯,汤懿珍.50例肺部鲍曼不动杆菌感染临床分析[J].临床肺科杂志,2012,17(6):1002-1003. 被引量:7
  • 10石岩,徐英春,刘晔,杜微,芮曦,王瑶.头孢哌酮-舒巴坦联合米诺环素治疗广泛耐药鲍曼不动杆菌感染[J].中华医学杂志,2012,92(40):2847-2850. 被引量:22

引证文献3

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部